Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals is a leading pharmaceutical company dedicated to developing and providing innovative solutions in diabetes diagnosis and treatment. Founded in 1998, Gan & Lee Pharmaceuticals has become a key supplier of insulin in China and is committed to expanding its global reach. The company focuses on making a positive impact on patient lives worldwide through its dedication to science and excellence.

Headquartered in the Tongzhou Economic Development Area, Beijing, at No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District, Beijing 101109, CN, Gan & Lee Pharmaceuticals operates with state-of-the-art GMP facilities. With a commitment to growth, Gan & Lee established a US subsidiary in New Jersey in 2014 and selected Linyi City, Shandong, as its second domestic drug production site in 2019, with plans to further expand into North America, Europe, and other regions.

The clinical development program at Gan & Lee Pharmaceuticals is actively investigating new chemical entities and biologics to treat cardiovascular and metabolic diseases, cancer, and other therapeutic areas. Gan & Lee Pharmaceuticals continues to push the boundaries of medical science to provide comprehensive and effective healthcare solutions. We invite the management of Gan & Lee Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform.